Brought to you by 
Cempra nets $54.7mm through IPO
29 Oct 2020
Executive Summary
Antibiotics developer Cempra Inc. has netted $54.7mm in its initial public offering of 9.66mm common shares (including the overallotment) at $6 each. Earlier this month the company announced plans to sell 6mm shares between $11-13.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cempra nets $54.7mm through IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice